3/2/15 Analyst IPO Blog

The NASDAQ Composite is approaching its March 2000 high during the peak of the tech bubble. It even reached 5,000 for the first time since 2000. Today's technology IPOs look much tamer in number than they did 15 years ago, but a boom in biotech IPOs raises concerns over a bubble in the biotech sector. Beware the biotech bubble • The NASDAQ Biotech Index is more than double its March 2000 peak • The average biotech ...more

Keywords: Biotech


RainDance Technologies, which sells systems that perform non-invasive genetic analysis, filed on Friday with the SEC to raise up to $60 million in an initial public offering. Genetic testing companies have been active in the IPO market this year. Invitae ([NVTA]) has gained 19% after it priced above the range in February. Autogenomics ([AGMX]) and AltheaDx ([IDGX]) planned to go public in February but postponed their deals. HTG Molecular ([HTGM]) recently updated its financials and could launch an IPO soon. RainDance lists Agilent Technologies (NYSE: A), Illumina (NASDAQ: ILMN) and Q...more

Keywords: RAIN, NVTA, A


Summit Materials, a Blackstone-backed provider of aggregates, concrete and asphalt paving services, announced terms for its IPO on Monday. The Denver, CO-based company plans to raise $400 million by offering 22.2 million shares at a price range of $17 to $19. At the midpoint of the proposed range, it would command a fully diluted market value of $1.7 billion. Summit Materials, which was founded in 2009 and booked $1.2 billion in sales for the 12 months ended December 31, 2014, plans to list on the NYSE under the symbol [SUM]. Citi, Goldman Sachs, BofA Merrill Lynch, Barclays, Deutsche ...more

Keywords: SUM, BX, VMC

3/1/15 Analyst IPO Blog

After a week without any IPOs, two upcoming deals - a biotech and an adtech - are set to kick off what could be a busy March in the IPO market. • 2 US IPOs on the IPO calendar • 2015 IPO activity remains below 2014 but above 2013 • The IPO pipeline contains several notable names to watch out for Voters in our

Archived News Headlines
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The Renaissance International IPO Index® (IPOXUS) is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO", the Renaissance International IPO ETF, symbol "IPOS" (the “ETFs”), and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the “Funds”) invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.